National Taiwan University Hospital: Hepatitis C trials
The registry lists 29 Hepatitis C studies with National Taiwan University Hospital as lead sponsor. 1 are open to participants now and 4 have results posted.
Phase 3 1Phase 4 10No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSMRecruitingNCT05751889Not applicable
- EBR/GZR for HCV-1b Patients Receiving HemodialysisCompletedNCT03420300Phase 4Results posted
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected PatientsCompletedNCT00495131Phase 4Results posted
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis CCompletedNCT00491244Phase 4Results posted
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose RibavirinCompletedNCT00491179Phase 4Results posted
- Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
- HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
- HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
- Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease.Status unknownNCT04618679
- eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAsCompletedNCT04047680
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsCompletedNCT03250910Phase 4
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis CStatus unknownNCT00980161
- Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II TestCompletedNCT00979979
- Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral LoadTerminatedNCT00977054Phase 4
- Investigation of Hepatitis B and Hepatitis C in TaiwanCompletedNCT00946010
- Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis CCompletedNCT00917358Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRCompletedNCT00532701Phase 4
- Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler IndicesCompletedNCT00466336
- Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation StudyCompletedNCT00466271
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal DiseaseCompletedNCT00172809Phase 4
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531